416 related articles for article (PubMed ID: 27121231)
1. A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF.
Ji J; Xu J; Li F; Li X; Gong W; Song Y; Dou H; Hou Y
Acta Biochim Biophys Sin (Shanghai); 2016 May; 48(5):411-9. PubMed ID: 27121231
[TBL] [Abstract][Full Text] [Related]
2. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
3. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
[TBL] [Abstract][Full Text] [Related]
4. A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
Yu C; Chen S; Zhou B; Zhang H; Su X; Luo Y; Yang L
Mol Immunol; 2021 Jan; 129():1-11. PubMed ID: 33254074
[TBL] [Abstract][Full Text] [Related]
5. Curcumin attenuates lupus nephritis in MRL/lpr mice by suppressing macrophage-secreted B cell activating factor (BAFF).
Li Q; Tan S; Xu K; Fu X; Yu J; Yang H; Wang H
Int J Clin Exp Pathol; 2019; 12(6):2075-2083. PubMed ID: 31934029
[TBL] [Abstract][Full Text] [Related]
6. Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men.
Schwarting A; Relle M; Meineck M; Föhr B; Triantafyllias K; Weinmann A; Roth W; Weinmann-Menke J
Lupus; 2018 Feb; 27(2):243-256. PubMed ID: 28659046
[TBL] [Abstract][Full Text] [Related]
7. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation.
Ma X; Che N; Gu Z; Huang J; Wang D; Liang J; Hou Y; Gilkeson G; Lu L; Sun L
Cell Transplant; 2013; 22(12):2279-90. PubMed ID: 23127285
[TBL] [Abstract][Full Text] [Related]
8. A new benzenediamine derivative modulates Toll-like receptors-induced myeloid dendritic cells activation and ameliorates lupus-like syndrome in MRLlpr/lpr mice.
Gao S; Gong Y; Ji J; Yuan L; Han L; Guo Y; Fan X; Hou Y; Hua C
Eur J Pharmacol; 2017 May; 803():94-102. PubMed ID: 28342978
[TBL] [Abstract][Full Text] [Related]
9. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
[TBL] [Abstract][Full Text] [Related]
10. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
Ju ZL; Shi GY; Zuo JX; Zhang JW;
Immunology; 2007 Feb; 120(2):281-9. PubMed ID: 17073941
[TBL] [Abstract][Full Text] [Related]
11. Activation of toll-like receptor-7 exacerbates lupus nephritis by modulating regulatory T cells.
Gong L; Wang Y; Zhou L; Bai X; Wu S; Zhu F; Zhu YF
Am J Nephrol; 2014; 40(4):325-44. PubMed ID: 25341693
[TBL] [Abstract][Full Text] [Related]
12. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
[TBL] [Abstract][Full Text] [Related]
13. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
14. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
Sugahara K; Maeda Y; Shimano K; Murase M; Mochiduki S; Takemoto K; Kakimoto T; Utsumi H; Oshita K; Kataoka H
J Immunol Res; 2019; 2019():5821589. PubMed ID: 31930150
[TBL] [Abstract][Full Text] [Related]
15. Triggering receptor expressed on myeloid cells-1 (TREM-1) deficiency augments BAFF production to promote lupus progression.
Liu CJ; Tsai CY; Chiang SH; Tang SJ; Chen NJ; Mak TW; Sun GH; Sun KH
J Autoimmun; 2017 Mar; 78():92-100. PubMed ID: 28089248
[TBL] [Abstract][Full Text] [Related]
16. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
17. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
18. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus.
Dong G; Yang Y; Li X; Yao X; Zhu Y; Zhang H; Wang H; Ma Q; Zhang J; Shi H; Ning Z; Yan F; Zhai W; Dai J; Li Z; Li C; Ming J; Xue Q; Meng X; Si C; Xiong H
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165554. PubMed ID: 31513833
[TBL] [Abstract][Full Text] [Related]
19. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
Jiang C; Zhao ML; Scearce RM; Diaz M
Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
[TBL] [Abstract][Full Text] [Related]
20. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
